What Researchers Did
Researchers evaluated the effectiveness of pharmacotherapy combined with hyperbaric oxygen (HBO) in nine patients with idiopathic sudden sensorineural hearing loss.
What They Found
The study found a statistically significant improvement in Pure Tone Audiometry results across multiple frequencies (500 Hz, 1 kHz, 2 kHz, 3 kHz, 4 kHz, and 8 kHz) after treatment. Significant differences were particularly noted at 500 Hz, 2 kHz, and 3 kHz when treatment began within 6 days, and no side effects were observed.
What This Means for Canadian Patients
Canadian patients experiencing sudden sensorineural hearing loss might benefit from a combination of pharmacotherapy and hyperbaric oxygen therapy. Early intervention, potentially within six days of onset, could lead to better hearing outcomes and reduced tinnitus.
Canadian Relevance
This study has no direct Canadian connection as it was conducted in Poland.
Study Limitations
A significant limitation of this study is its very small sample size of only nine patients.